MRI criteria for MS in patients with clinically isolated syndromes.

MRI criteria for MS in patients with clinically isolated syndromes.

In recent years, criteria for the diagnosis of multiple sclerosis (MS) have changed, mainly due to the incorporation of new MRI criteria. While the new criteria are a logical step forward, they are complex and-not surprisingly-a good working knowledge of them is not always evident among neurologists...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Montalban, X, Tintoré, M, Swanton, J, Barkhof, F, Fazekas, F, Filippi, M, Frederiksen, J, Kappos, L, Palace, J, Polman, C, Rovaris, M, de Stefano, N, Thompson, A, Yousry, T, Rovira, A, Miller, D
Format:	Journal article
Język:	English
Wydane:	2010

Podobne zapisy

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.
od: Seewann, A, i wsp.
Wydane: (2008)

Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study.
od: Rocca, M, i wsp.
Wydane: (2009)

The current role of MRI in differentiating multiple sclerosis from its imaging mimics
od: Geraldes, R, i wsp.
Wydane: (2018)

MRI assessment of iron deposition in multiple sclerosis.
od: Ropele, S, i wsp.
Wydane: (2011)

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study.
od: Wegner, C, i wsp.
Wydane: (2008)

Functional connectivity changes of the motor network in patients with multiple sclerosis: a multicentre fMRI study
od: Rocca, M, i wsp.
Wydane: (2009)

Functional connectivity changes of the motor network in patients with multiple sclerosis: a multi-centre fMRI study
od: Filippi, M, i wsp.
Wydane: (2009)

MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.
od: Matthews, L, i wsp.
Wydane: (2014)

Intercenter differences in diffusion tensor MRI acquisition.
od: Pagani, E, i wsp.
Wydane: (2010)

Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
od: Korteweg, T, i wsp.
Wydane: (2009)

Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
od: Wallner-Blazek, M, i wsp.
Wydane: (2014)

Erratum: Atypical idiopathic inflammatory demyelinating lesions: Prognostic implications and relation to multiple sclerosis (Journal of Neurology (2013) 260 (2016-2022) DOI: 10.1007/s00415-013-6918-y)
od: Wallner-Blazek, M, i wsp.
Wydane: (2014)

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition.
od: Manson, S, i wsp.
Wydane: (2008)

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
od: Wallner-Blazek, M, i wsp.
Wydane: (2013)

Atypical idiopathic inflammatory demyelinating lesions: Prognostic implications and relation to multiple sclerosis
od: Wallner-Blazek, M, i wsp.
Wydane: (2013)

Reproducibility of fMRI in the clinical setting: implications for trial designs.
od: Bosnell, R, i wsp.
Wydane: (2008)

Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis.
od: Mancini, L, i wsp.
Wydane: (2009)

MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies
od: Nicola De Stefano, i wsp.
Wydane: (2022-01-01)

Optimising diffusion measurements for large-scale, multicentre multiple sclerosis trials: a pan-European study
od: Perego, E, i wsp.
Wydane: (2008)

Optimizing diffusion measurements for large-scale, multicenter multiple sclerosis trials: a pan-European study
od: Rovaris, M, i wsp.
Wydane: (2008)

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial.
od: Filippi, M, i wsp.
Wydane: (2004)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
od: Vrenken, H, i wsp.
Wydane: (2013)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
od: Vrenken, H, i wsp.
Wydane: (2013)

Association between pathological and MRI findings in multiple sclerosis.
od: Filippi, M, i wsp.
Wydane: (2012)

Association between pathological and MRI findings in multiple sclerosis
od: Filippi, M, i wsp.
Wydane: (2012)

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
od: Nielsen Jessica M, i wsp.
Wydane: (2009-05-01)

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
od: Houshang Amiri, i wsp.
Wydane: (2018-01-01)

Brain MRI atrophy quantification in MS: From methods to clinical application.
od: Rocca, M, i wsp.
Wydane: (2016)

BEFORE AND AFTER THE ACUTE MS LESION: A LONGITUDINAL DTI STUDY
od: Giorgio, A, i wsp.
Wydane: (2009)

Improved MRI-derived assessment of grey and white matter volumes by using SIENAX
od: Battaglini, M, i wsp.
Wydane: (2013)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
od: Jurynczyk, M, i wsp.
Wydane: (2016)

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.
od: Georgina Arrambide, i wsp.
Wydane: (2013-01-01)

MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex.
od: Parry, A, i wsp.
Wydane: (2003)

Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX.
od: Jasperse, B, i wsp.
Wydane: (2007)

Diagnostic Criteria for Pediatric MS
od: J Gordon Millichap
Wydane: (2013-06-01)

Partnership and consent in MS treatment choice.
od: Palace, J
Wydane: (2013)

Partnership and consent in MS treatment choice
od: Palace, J
Wydane: (2013)

The UK MS database
od: Palace, J, i wsp.
Wydane: (2002)

Clinical and laboratory characteristics of secondary progressive MS.
od: Palace, J
Wydane: (2003)

To differentiate the indication to treat the clinically isolated syndrome on the bases of different clinical onsets. The subgroup analyses from a Cochrane meta-analysis
od: Clerico, M, i wsp.
Wydane: (2009)